Mutation screening of the tau gene in patients with early-onset Alzheimer's disease

Neurosci Lett. 1999 Dec 24;277(2):137-9. doi: 10.1016/s0304-3940(99)00861-7.

Abstract

Hyperphosphorylated microtubule associated protein tau, present in neurofibrillary tangles, is a prominent pathological feature of Alzheimer's disease (AD). The gene encoding tau (MAPT) was recently found mutated in frontotemporal dementia (FTD) and other tauopathies. We studied MAPT as a candidate gene in the etiology of AD. The study population consisted of 101 early-onset AD patients and 117 controls. Mutation analysis did not detect causal mutations in exons 9 to 13 encoding the microtubule-binding domains involved in FTD, however, two novel polymorphisms were detected in exon 9. Using the Ala169 polymorphism in exon 9 and a previously reported (CA)n-repeat polymorphism in intron 9, an association study was performed. No association with early-onset AD was detected. Together, our data indicate that MAPT does not play a role in early-onset AD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alleles
  • Alzheimer Disease / genetics*
  • DNA Mutational Analysis
  • Exons / genetics*
  • Genotype
  • Humans
  • Introns / genetics*
  • Middle Aged
  • Polymorphism, Genetic / genetics*
  • tau Proteins / genetics*

Substances

  • tau Proteins